moderna hhs - Search News

Order byBest matchMost fresh

HHS cancels funding for Moderna bird flu vaccine

Digest more

HHS cancels $590 million contract with Moderna for bird flu vaccine

HHS said Wednesday that the project doesn’t meet scientific or safety expectations for continued investment.

· 2d · on MSN

STAT · 14h

HHS cancels $766 million in Moderna contracts for vaccines for flu pandemics

· 1d · on MSN

HHS pulls millions in funding for Moderna to develop bird flu vaccines

The scientists aiming to stay ahead of bird flu on dairy farms and prevent a human pandemic

So far, the only people to come down with bird flu got it from animals.

· 1d

· 17h

Government pulls money for bird flu vaccine development over mRNA concerns

· 1d

Trump Administration Cancels $600 Million Contract to Develop Bird Flu Vaccine

Pfizer CEO: HHS claims of ‘concealed safety concerns’ on mRNA vaccines are ‘completely inaccurate’

“MRNA probably is the most utilized vaccine in the history of humanity,” Pfizer CEO Dr. Albert Bourla said Friday, noting that there have been about 1.5 billion mRNA vaccine doses against Covid-19 adm...

· 11h

· 1d

Why is Trump's administration cutting bird flu vaccine funding?

· 1d

Trump administration cancels Moderna contract to fight bird flu and other viruses

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE

NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mNEXSPIKE® (mRNA-1283),

Moderna Announces Update on Investigational Pandemic Influenza Program

H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award for late-stage development of pre-pandemic influenza vaccines CAMBRIDGE, MA / ACCESS Newswire / May 28,

Endpoints News2d

The fate of Moderna’s next-gen Covid shot looms large after a flurry of policy changes

The US’ stance on Covid-19 vaccines under HHS chief Robert F. Kennedy Jr. is coming into focus with a new approval framework, new immunization guidance and, more broadly, a new attitude about the vaccines’ usefulness.